A Middletown, Delaware–based firm concentrating on early-phase biotech and life sciences. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Early investor in AI applications and infrastructure, led by active AI practitioners Socher, Manning, and Goldbloom who continue hands-on research and company-building, providing domain expertise and founder partnership. The firm continues to build its presence across the venture capital landscape.
Co-founds and incubates emerging ventures upwards of 4–18 months inside the Allen Institute for AI's frontier research ecosystem, providing up to $600k, $1M non-dilutive cloud credits, and ~7% SAFE. The firm continues to build its presence across the venture capital landscape.
Headed by consumer-brand operator Susan Lyne and born of #BUILTBYGIRLS, they use a internally developed Polyculture thesis and data from 100+ female-led companies to guide company builders exploring polycultural markets.
Champions mission-driven company builders harnessing science and technology to deliver on the UN Sustainable Development Goals.
Stealthy investor across frontier sectors (space, biotech, AI) making sub-$500K average checks into technically complex startup ventures with exceptional defensibility and operational guidance from GP Rob Ness’s 2% Rule. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Global alternative-protein accelerator with a five-month program (New York, Singapore, Paris), backing consumer and enabling-technology-driven emerging ventures and extending direct access to incumbents like AAK, Bel, Bühler, Givaudan, Tyson Ventures. With a disciplined investment approach, the team drives value for both founders and investors.
